Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

India-led research effort asks the question: How do we keep a potential COVID-19 vaccine cold?

By Chris Newmarker | May 8, 2020

India COVID-19 vaccine University of Birmingham

[Image courtesy of University of Birmingham]

U.K. scientists have joined a research effort in India to help solve distribution problems around whatever COVID-19 vaccine hopefully emerges from global efforts, according to a recent news release from the University of Birmingham.

Backed by the Shakti Sustainable Energy Foundation, experts from the University of Birmingham and Heriot-Watt University, Edinburgh are investigating the challenge involved in distributing a potentially temperature-sensitive COVID–19 vaccine.

The Centre for Environment Education (CEE) in India is leading the overall research, with support from commercial partners such as Zanotti (a part of the Daikin Group), Sure Chill and Nexleaf Analytics. The British researchers are exploring how integrated “Community Cooling Hubs’” can integrate food cold chains with other cold-dependent services such as community health facilities, social facilities and even emergency services.

“We may have 12-18 months to engineer a robust, efficient distribution system to ensure any vaccine for COVID–19 can reach the world’s population, whether they are in urban or remote rural areas,” said professor Phil Greening from the Centre for Sustainable Road Freight at Heriot-Watt University.

“A radical approach like community cooling hubs could help meet the different communities’ cooling needs in a clean, affordable and sustainable way while helping to safeguard people’s health,” Greening said in a news release out yesterday.

Toby Peters, professor of cold economy at the University of Birmingham, said universal vaccine access is already a major challenge. “With COVID–19, rapid mass immunization will probably be required; maintaining a continuous cold chain to rapidly transport and deliver COVID–19 vaccines to all communities, many where electricity supply and cooling infrastructure is often non-existent or unreliable, will be a daunting task.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards